88
Participants
Start Date
December 21, 2022
Primary Completion Date
September 12, 2025
Study Completion Date
September 12, 2025
Nintedanib
Nintedanib
Private physician, Athens
Private physician, Athens
"G. Gennimatas General Hospital of Athens", Athens
"Ippokration General Hospital of Athens", Athens
"Laiko General Hospital of Athens", Athens
Private physician, Athens
"ATTIKON University General Hospital", Athens
"KAT General Hospital", Athens
Private physician, Nea Smirni, Athens
Private physician, Pátrai
University General Hospital of Patra, Pátrai
Private physician, Larissa
University General Hospital of Larisa, Larissa
Private physician, Ioannina
University General Hospital of Ioannina, Ioannina
Private physician, Thessaloniki
"Hippokration General Hospital of Thessaloniki", Thessaloniki
"G. Papanikolaou General University of Thessaloniki", Thessaloniki
"Clinic Agios Loukas", Thessaloniki
University General Hospital of Heraklion, Heraklion
University General Hospital of Heraklion, Heraklion
Lead Sponsor
Boehringer Ingelheim
INDUSTRY